Home » Topics » Regulatory

Regulatory
RSS

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Timentin cleared for pediatric use in U.S.

Jan. 22, 1998

Pfizer to develop Nastech formulation of sleep aid

Jan. 21, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.